Bruker Corporation (BRKR)

業務介紹

Bruker Corporation（布魯克公司）在美國和國際市場上開發、製造和分銷科學儀器以及分析和診斷解決方案。該公司通過三個部門運營：Bruker Scientific Instruments（BSI）生命科學、BSI NANO和Bruker Energy＆Supercon Technologies。它提供生命科學工具和單一和多模態系統；生命科學質譜儀；MALDI Biotyper快速病原體鑒定平台及相關試劑盒、DNA試紙條和基於螢光的聚合酶鏈反應技術；基因型和螢光型分子診斷試劑盒；研究、分析和過程分析儀器和解決方案；用於COVID-19感染診斷的SARS-CoV 2測試；以及Fluorotyper-SARS-CoV 2 plus試劑盒。它還提供一系列便攜式分析和生物分析檢測系統及相關產品；X射線儀器；電子顯微鏡的分析工具，以及手持式、便攜式和移動式X射線螢光光譜儀；原子力顯微鏡儀器；非接觸納米解析度表面形貌解決方案；以及自動化X射線計量、自動化AFM缺陷檢測和光罩修復和清潔設備。此外，該公司還提供先進的光學螢光顯微鏡儀器；產品和服務以支持轉化研究、藥物和生物標記物發現的多組學需求；超導材料，如金屬低溫超導體；基於金屬低溫超導體的設備和複雜工具；以及非超導高技術工具，如同步輻射和光束線儀器。Bruker Corporation與Newomics Inc.合作開發了一種用於藥物發現的液相色譜-質譜（LC-MS）平台。該公司成立於1991年，總部位於麻薩諸塞州比勒里卡市。

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

公司網址

https://www.bruker.com